Those submissions are in different stages of review, obviously, just starting, the Novavax rolling submission now with their initial data being provided. By contrast, as I noted previously, we're at the final stage of our review of the AstraZeneca submission and are working closely with the company for the remaining information that will allow us to complete our review of that in the very short term.
On February 2nd, 2021. See this statement in context.